Index RUT P/E - EPS (ttm) -0.14 Insider Own 1.22% Shs Outstand 77.49M Perf Week -2.31%
Market Cap 3.14B Forward P/E 63.68 EPS next Y 0.64 Insider Trans -16.10% Shs Float 76.55M Perf Month -6.35%
Income -9.27M PEG - EPS next Q 0.11 Inst Own 106.07% Short Float 3.65% Perf Quarter 16.88%
Sales 425.33M P/S 7.39 EPS this Y 135.29% Inst Trans 2.61% Short Ratio 3.68 Perf Half Y 69.58%
Book/sh 15.18 P/B 2.67 EPS next Y 77.02% ROA -0.77% Short Interest 2.79M Perf Year 58.52%
Cash/sh 3.54 P/C 11.47 EPS next 5Y - ROE -0.83% 52W Range 18.61 - 46.00 Perf YTD 2.47%
Dividend Est. - P/FCF 55.68 EPS past 5Y -10.52% ROI -0.78% 52W High -11.78% Beta 1.70
Dividend TTM - Quick Ratio 4.79 Sales past 5Y 35.32% Gross Margin 64.93% 52W Low 118.05% ATR (14) 1.90
Dividend Ex-Date - Current Ratio 5.08 EPS Y/Y TTM 79.63% Oper. Margin 2.65% RSI (14) 47.05 Volatility 4.70% 4.43%
Employees 815 Debt/Eq 0.02 Sales Y/Y TTM 23.95% Profit Margin -2.18% Recom 1.67 Target Price 44.50
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 147.47% Payout - Rel Volume 3.39 Prev Close 41.10
Sales Surprise 5.50% EPS Surprise 486.42% Sales Q/Q 28.58% Earnings Nov 06 AMC Avg Volume 758.76K Price 40.58
SMA20 -1.40% SMA50 -0.72% SMA200 36.02% Trades
Volume 2,570,901 Change -1.27%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-05-24 Downgrade Goldman
Buy → Neutral
$38 → $37
Nov-15-24 Initiated Wolfe Research
Outperform
$50
Oct-16-24 Initiated UBS
Buy
$43
Oct-10-24 Initiated Guggenheim
Buy
$40
Feb-23-24 Reiterated Needham
Buy
$30 → $33
Jan-18-23 Downgrade Raymond James
Outperform → Mkt Perform
Jan-05-23 Initiated Scotiabank
Sector Outperform
$33
Jan-07-22 Initiated Stephens
Overweight
$52
Nov-18-21 Resumed Goldman
Buy
$60
Jun-15-21 Initiated Raymond James
Outperform
$45
Feb-18-21 Resumed Needham
Buy
$88
Jan-28-21 Initiated Truist
Buy
$61
Nov-10-20 Initiated KeyBanc Capital Markets
Sector Weight
$48
Sep-09-20 Initiated Morgan Stanley
Underweight
$35
Jul-31-19 Initiated Lake Street
Buy
$35
Jul-02-19 Initiated Needham
Buy
$33
Nov-29-18 Downgrade Janney
Buy → Neutral
Oct-31-18 Upgrade Janney
Neutral → Buy
Nov-07-17 Downgrade Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade Janney
Buy → Neutral
Show Previous Ratings
Dec-12-24 10:39AM
(Investor's Business Daily)
09:18AM
Dec-05-24 04:05PM
Nov-27-24 04:51PM
(Investor's Business Daily)
Nov-07-24 10:01AM
06:10PM
Loading…
Nov-06-24 06:10PM
05:05PM
(Associated Press Finance)
04:05PM
Nov-05-24 07:43AM
Oct-30-24 05:00PM
Oct-16-24 06:43PM
Oct-09-24 05:07PM
Oct-02-24 05:02PM
08:20AM
Sep-15-24 08:45AM
07:01PM
Loading…
Sep-06-24 07:01PM
Sep-05-24 11:31AM
Sep-04-24 04:05PM
09:50AM
Aug-26-24 05:30PM
09:00AM
04:36AM
Aug-19-24 09:55AM
Aug-15-24 09:50AM
Aug-14-24 09:15AM
Aug-09-24 07:22PM
Aug-08-24 09:09AM
Aug-07-24 02:08PM
Aug-06-24 06:25PM
05:24PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Jul-24-24 10:57AM
Jul-19-24 12:01AM
Jul-17-24 05:00PM
04:48AM
Jun-21-24 09:55AM
Jun-06-24 11:31AM
Jun-03-24 04:05PM
May-29-24 09:55AM
09:30AM
May-28-24 09:31AM
08:47AM
08:32AM
May-23-24 10:00AM
May-22-24 04:05PM
May-21-24 09:59AM
May-15-24 05:04PM
May-13-24 09:55AM
May-08-24 03:13PM
08:55AM
07:12AM
(Thomson Reuters StreetEvents)
03:48AM
May-07-24 10:55PM
06:13PM
(Associated Press Finance)
06:00PM
04:05PM
May-06-24 04:05PM
Apr-22-24 05:00PM
08:30AM
Apr-16-24 08:30AM
Apr-02-24 10:33AM
Feb-27-24 05:55PM
Feb-26-24 03:20PM
Feb-23-24 11:10AM
07:43AM
07:37AM
(Thomson Reuters StreetEvents)
Feb-22-24 06:05PM
05:03PM
(Associated Press Finance)
04:40PM
04:05PM
Feb-21-24 05:00PM
Feb-08-24 08:00AM
Feb-06-24 08:15AM
Jan-08-24 08:00AM
Dec-12-23 04:30PM
Dec-01-23 04:05PM
Nov-29-23 08:30AM
Nov-22-23 08:30AM
Nov-08-23 04:39PM
Nov-07-23 04:57PM
(Associated Press Finance)
04:05PM
04:00PM
Nov-02-23 08:15AM
Oct-27-23 08:30AM
Oct-26-23 02:50PM
Oct-17-23 08:15AM
Oct-16-23 10:43AM
Oct-12-23 09:00AM
Oct-04-23 04:05PM
Sep-28-23 04:05PM
08:15AM
Sep-27-23 09:00AM
Sep-21-23 04:05PM
Sep-07-23 04:05PM
Sep-06-23 08:15AM
Sep-02-23 06:15AM
Aug-29-23 08:15AM
Aug-22-23 08:15AM
Aug-15-23 04:15PM
Aug-08-23 06:05PM
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
EPSTEIN ROBERT S Director Jan 06 '25 Option Exercise 8.04 20,000 160,800 64,598 Jan 08 04:47 PM EASTHAM KARIN Director Jan 02 '25 Option Exercise 5.28 10,000 52,800 28,497 Jan 06 05:16 PM EASTHAM KARIN Director Jan 02 '25 Sale 40.30 10,000 403,006 18,497 Jan 06 05:16 PM KARIN EASTHAM Director Jan 02 '25 Proposed Sale 39.60 10,000 396,000 Jan 02 04:23 PM Stapley Marc Chief Executive Officer Dec 13 '24 Sale 43.42 5,590 242,737 307,345 Dec 17 04:31 PM MARC STAPLEY Director Dec 13 '24 Proposed Sale 44.40 5,590 248,196 Dec 13 04:27 PM Febbo Phillip G. Chief Scientific & Med Officer Dec 04 '24 Sale 44.09 3,934 173,447 82,414 Dec 06 04:34 PM McGuire Annie SVP, General Counsel Dec 04 '24 Sale 44.02 18,699 823,179 72,869 Dec 06 04:34 PM PHILLIP G FEBBO Officer Dec 04 '24 Proposed Sale 44.09 1,311 57,802 Dec 05 05:24 PM Leite John Chief Commercial Officer-CLIA Dec 03 '24 Sale 43.25 1,050 45,408 73,810 Dec 04 04:59 PM Chambers Rebecca Chief Financial Officer Dec 03 '24 Sale 43.23 7,000 302,622 114,037 Dec 04 04:59 PM Wygant Jonathan VP, Chief Accounting Officer Dec 03 '24 Sale 43.36 956 41,452 40,270 Dec 04 04:59 PM PHILLIP G FEBBO Officer Dec 04 '24 Proposed Sale 43.66 2,623 114,520 Dec 04 04:38 PM ANN MCGUIRE Officer Dec 04 '24 Proposed Sale 43.66 18,699 816,398 Dec 04 04:35 PM REBECCA CHAMBERS Officer Dec 03 '24 Proposed Sale 44.12 7,527 332,091 Dec 03 04:32 PM JOHN LEITE Officer Dec 03 '24 Proposed Sale 44.12 1,050 46,326 Dec 03 04:31 PM Wygant Jonathan VP, Chief Accounting Officer Nov 27 '24 Sale 42.89 5,032 215,834 42,313 Nov 29 02:28 PM EASTHAM KARIN Director Nov 19 '24 Sale 38.34 14,731 564,768 18,497 Nov 21 04:36 PM KARIN EASTHAM Director Nov 19 '24 Proposed Sale 36.71 14,731 540,775 Nov 19 04:23 PM Chambers Rebecca Chief Financial Officer Nov 12 '24 Sale 38.34 15,275 585,663 124,501 Nov 14 04:35 PM EPSTEIN ROBERT S Director Nov 12 '24 Option Exercise 8.04 15,000 120,600 59,598 Nov 14 04:35 PM EPSTEIN ROBERT S Director Nov 12 '24 Sale 38.32 15,000 574,830 44,598 Nov 14 04:35 PM ROBERT S EPSTEIN Director Nov 12 '24 Proposed Sale 38.89 15,000 583,350 Nov 12 04:29 PM REBECCA CHAMBERS Officer Nov 12 '24 Proposed Sale 38.89 15,275 594,045 Nov 12 04:29 PM JONES EVAN/ FA Director Sep 19 '24 Sale 35.23 5,173 182,263 0 Sep 23 04:23 PM Leite John Chief Commercial Officer-CLIA Sep 04 '24 Sale 29.78 5,479 163,159 76,174 Sep 06 04:18 PM JOHN LEITE Officer Sep 04 '24 Proposed Sale 30.29 5,479 165,959 Sep 04 04:17 PM JONES EVAN/ FA Director Aug 13 '24 Option Exercise 10.41 8,486 88,339 54,800 Aug 14 05:09 PM JONES EVAN/ FA Director Aug 13 '24 Sale 32.20 27,188 875,565 5,173 Aug 14 05:09 PM JONES EVAN/ FA Director Aug 13 '24 Sale 32.20 20,457 658,801 34,343 Aug 14 05:09 PM JONES EVAN/ FA Director Aug 12 '24 Sale 30.00 101 3,031 32,361 Aug 14 05:09 PM JONES EVAN/ FA Director Aug 12 '24 Sale 30.01 99 2,971 46,314 Aug 14 05:09 PM JONES EVAN/ FA Director Aug 09 '24 Option Exercise 10.41 300 3,123 47,445 Aug 13 04:38 PM JONES EVAN/ FA Director Aug 09 '24 Sale 30.03 1,032 30,990 46,413 Aug 13 04:38 PM JONES EVAN/ FA Director Aug 09 '24 Sale 30.03 746 22,402 32,462 Aug 13 04:38 PM Holstein Jens Director Aug 07 '24 Sale 29.00 5,000 145,000 27,878 Aug 09 04:47 PM JONES EVAN/ FA Director Aug 07 '24 Option Exercise 10.41 1,214 12,638 50,288 Aug 09 04:47 PM JONES EVAN/ FA Director Aug 07 '24 Sale 30.32 5,108 154,883 45,180 Aug 09 04:47 PM Evan Jones Director Aug 07 '24 Proposed Sale 27.05 59,904 1,620,403 Aug 07 07:52 PM EASTHAM KARIN Director Jul 16 '24 Sale 25.00 7,500 187,500 33,228 Jul 18 06:25 PM Leite John Chief Commercial Officer-CLIA Jul 16 '24 Sale 25.00 1,277 31,925 82,968 Jul 18 06:25 PM Holstein Jens Director Jul 16 '24 Sale 24.50 5,000 122,500 32,878 Jul 18 06:25 PM EASTHAM KARIN Director Jun 11 '24 Sale 20.59 3,870 79,683 29,255 Jun 13 04:24 PM Bhanji Muna Director Jun 10 '24 Sale 20.32 3,870 78,634 23,105 Jun 11 04:22 PM EASTHAM KARIN Director Jun 07 '24 Option Exercise 10.41 2,500 26,025 35,625 Jun 11 04:21 PM EASTHAM KARIN Director Jun 07 '24 Sale 20.97 2,500 52,425 33,125 Jun 11 04:21 PM Bhanji Muna Director May 28 '24 Sale 21.00 1,539 32,319 26,975 May 30 04:41 PM EASTHAM KARIN Director Apr 01 '24 Option Exercise 13.19 10,000 131,900 43,125 Apr 02 04:17 PM EASTHAM KARIN Director Apr 01 '24 Sale 21.65 10,000 216,528 33,125 Apr 02 04:17 PM JONES EVAN/ FA Director Mar 01 '24 Option Exercise 13.19 10,000 131,900 47,601 Mar 05 05:28 PM JONES EVAN/ FA Director Mar 01 '24 Sale 24.36 10,000 243,599 37,601 Mar 05 05:28 PM
Index RUT P/E - EPS (ttm) -2.96 Insider Own 3.63% Shs Outstand 55.09M Perf Week -0.09%
Market Cap 8.62B Forward P/E - EPS next Y -1.05 Insider Trans -2.76% Shs Float 53.14M Perf Month 8.51%
Income -149.57M PEG - EPS next Q -0.38 Inst Own 99.58% Short Float 5.72% Perf Quarter 21.99%
Sales 360.35M P/S 23.93 EPS this Y 19.74% Inst Trans 1.61% Short Ratio 5.17 Perf Half Y 31.74%
Book/sh 12.13 P/B 12.89 EPS next Y 42.39% ROA -15.95% Short Interest 3.04M Perf Year 74.99%
Cash/sh 4.76 P/C 32.85 EPS next 5Y - ROE -26.10% 52W Range 83.90 - 161.13 Perf YTD 4.30%
Dividend Est. - P/FCF - EPS past 5Y -49.95% ROI -18.12% 52W High -2.94% Beta 1.05
Dividend TTM - Quick Ratio 4.71 Sales past 5Y 8.27% Gross Margin 78.14% 52W Low 86.40% ATR (14) 5.42
Dividend Ex-Date - Current Ratio 5.54 EPS Y/Y TTM -10.22% Oper. Margin -30.50% RSI (14) 60.15 Volatility 4.39% 3.33%
Employees 907 Debt/Eq 0.24 Sales Y/Y TTM 18.70% Profit Margin -41.51% Recom 1.69 Target Price 157.31
Option/Short Yes / Yes LT Debt/Eq 0.24 EPS Q/Q 37.80% Payout - Rel Volume 0.90 Prev Close 156.51
Sales Surprise 5.66% EPS Surprise 41.40% Sales Q/Q 23.86% Earnings Nov 04 AMC Avg Volume 587.94K Price 156.39
SMA20 3.14% SMA50 7.95% SMA200 25.23% Trades
Volume 529,005 Change -0.08%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-11-24 Upgrade Citigroup
Neutral → Buy
$132 → $162
Dec-06-24 Initiated UBS
Buy
$182
Dec-02-24 Downgrade Morgan Stanley
Equal-Weight → Underweight
$120
Jul-10-24 Downgrade Citigroup
Buy → Neutral
$132
May-06-24 Upgrade Jefferies
Hold → Buy
$84 → $125
Dec-21-23 Upgrade JP Morgan
Neutral → Overweight
$66 → $91
Dec-04-23 Initiated Morgan Stanley
Equal-Weight
$65
Nov-28-23 Initiated Truist
Buy
$88
Nov-08-23 Upgrade Wells Fargo
Equal Weight → Overweight
$75 → $83
Jun-07-23 Upgrade Piper Sandler
Neutral → Overweight
$55 → $80
Dec-22-22 Initiated Mizuho
Neutral
$48
Dec-19-22 Upgrade JP Morgan
Underweight → Neutral
$48 → $42
Dec-12-22 Upgrade Citigroup
Neutral → Buy
$57
Oct-14-22 Resumed Stephens
Overweight
$69
Oct-04-22 Initiated Needham
Buy
$66
Jul-12-22 Upgrade Stifel
Hold → Buy
$40 → $60
Feb-03-22 Upgrade William Blair
Mkt Perform → Outperform
Jan-19-22 Upgrade Wells Fargo
Underweight → Equal Weight
$56
Jan-18-22 Upgrade BTIG Research
Neutral → Buy
$61
Nov-03-21 Upgrade Stephens
Equal-Weight → Overweight
$68
Show Previous Ratings
Jan-14-25 04:05PM
Jan-04-25 07:45AM
Dec-23-24 07:00AM
Dec-19-24 07:30AM
Dec-17-24 07:00AM
05:35AM
Loading…
Dec-07-24 05:35AM
Dec-02-24 02:29PM
Nov-08-24 07:00AM
Nov-06-24 06:30AM
Nov-05-24 11:30AM
11:18AM
(Thomson Reuters StreetEvents)
02:08AM
Nov-04-24 05:25PM
04:25PM
(Associated Press Finance)
04:05PM
09:01AM
Loading…
Nov-01-24 09:01AM
Oct-28-24 10:01AM
Oct-17-24 10:06AM
(Pharmaceutical Technology)
Oct-16-24 04:05PM
Oct-14-24 07:00AM
Oct-09-24 07:00AM
Sep-09-24 05:16AM
Sep-03-24 02:16AM
Aug-22-24 01:16PM
Aug-16-24 07:00AM
Aug-02-24 07:00PM
08:50AM
Aug-01-24 11:40AM
(Thomson Reuters StreetEvents)
07:31AM
Jul-31-24 09:57PM
06:20PM
Loading…
06:20PM
05:16PM
(Associated Press Finance)
04:05PM
Jul-24-24 10:01AM
Jul-22-24 11:27AM
Jul-10-24 07:00AM
Jul-03-24 07:38AM
Jun-27-24 12:49PM
03:19AM
Jun-14-24 07:00AM
Jun-05-24 12:14PM
Jun-03-24 01:53PM
May-28-24 07:00AM
May-14-24 04:47PM
12:20PM
May-02-24 12:01PM
11:59AM
09:14AM
07:12AM
(Thomson Reuters StreetEvents)
03:38AM
May-01-24 11:53PM
05:50PM
05:35PM
04:50PM
(Associated Press Finance)
04:05PM
Apr-16-24 04:05PM
Apr-15-24 08:19AM
Apr-12-24 09:22AM
Apr-10-24 07:00AM
Apr-08-24 10:41AM
Apr-04-24 12:02PM
Apr-03-24 07:00AM
Apr-01-24 07:00AM
Mar-22-24 11:30AM
Mar-13-24 07:56AM
Feb-27-24 02:03AM
Feb-22-24 10:16AM
08:58AM
07:47AM
(Thomson Reuters StreetEvents)
Feb-21-24 05:20PM
04:35PM
04:17PM
(Associated Press Finance)
04:05PM
Feb-15-24 02:04AM
Feb-14-24 10:00AM
08:15AM
Feb-01-24 03:01PM
Jan-31-24 07:00AM
Jan-30-24 10:42AM
Jan-18-24 07:57PM
Jan-16-24 07:41AM
Jan-11-24 11:26AM
Jan-09-24 07:00AM
Dec-23-23 01:01AM
Dec-21-23 01:31AM
Dec-20-23 07:00AM
Dec-19-23 01:28PM
Dec-18-23 09:49AM
Dec-15-23 05:57AM
Dec-14-23 07:45AM
07:00AM
Dec-03-23 10:30AM
Dec-01-23 11:31AM
Nov-15-23 08:00AM
Nov-07-23 07:00AM
Nov-02-23 06:17PM
10:34AM
Nov-01-23 07:00PM
06:07PM
04:57PM
(Associated Press Finance)
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gilliam Joseph E PRESIDENT & COO Dec 20 '24 Option Exercise 59.74 3,328 198,830 105,497 Dec 23 09:15 PM Gilliam Joseph E PRESIDENT & COO Dec 20 '24 Sale 149.85 3,328 498,716 102,169 Dec 23 09:15 PM Kliman Gilbert H Director Dec 20 '24 Option Exercise 32.00 10,000 320,000 42,336 Dec 23 07:53 PM Kliman Gilbert H Director Dec 20 '24 Sale 150.28 10,000 1,502,800 32,336 Dec 23 07:53 PM Gilliam Joseph E Officer Dec 20 '24 Proposed Sale 149.85 3,657 548,017 Dec 20 04:27 PM Kliman Gilbert H Director Dec 20 '24 Proposed Sale 150.28 10,000 1,502,789 Dec 20 04:21 PM Kliman Gilbert H Director Dec 11 '24 Option Exercise 32.00 2,000 64,000 34,336 Dec 13 07:50 PM Kliman Gilbert H Director Dec 11 '24 Sale 144.01 2,000 288,020 32,336 Dec 13 07:50 PM Kliman Gilbert H Director Dec 11 '24 Proposed Sale 144.01 2,000 288,015 Dec 11 12:32 PM Gilliam Joseph E PRESIDENT & COO Oct 30 '24 Option Exercise 69.30 2,275 157,658 104,444 Nov 01 05:30 PM Gilliam Joseph E PRESIDENT & COO Oct 30 '24 Sale 138.97 2,275 316,157 102,169 Nov 01 05:30 PM Gilliam Joseph E Officer Oct 30 '24 Proposed Sale 138.97 2,500 347,421 Oct 30 04:18 PM Kliman Gilbert H Director Sep 09 '24 Option Exercise 32.00 3,000 96,000 35,336 Sep 11 07:49 PM Kliman Gilbert H Director Sep 09 '24 Sale 130.67 3,000 392,000 32,336 Sep 11 07:49 PM Kliman Gilbert H Director Sep 09 '24 Proposed Sale 130.67 3,000 392,000 Sep 09 03:03 PM Gilliam Joseph E PRESIDENT & COO Aug 21 '24 Option Exercise 55.18 5,000 275,900 107,169 Aug 23 05:25 PM Gilliam Joseph E PRESIDENT & COO Aug 21 '24 Sale 129.36 5,000 646,791 102,169 Aug 23 05:25 PM Gilliam Joseph E Officer Aug 21 '24 Proposed Sale 129.36 5,000 646,803 Aug 21 04:19 PM Stapley Marc Director Aug 15 '24 Option Exercise 32.00 6,250 200,000 40,326 Aug 19 05:15 PM Stapley Marc Director Aug 15 '24 Sale 125.93 6,250 787,086 34,076 Aug 19 05:15 PM Stapley Marc Director Aug 15 '24 Proposed Sale 125.93 6,250 787,074 Aug 15 05:12 PM WEISNER AIMEE S Director Aug 08 '24 Option Exercise 32.00 25,000 800,000 55,119 Aug 12 05:05 PM WEISNER AIMEE S Director Aug 08 '24 Sale 120.00 25,000 3,000,000 30,119 Aug 12 05:05 PM WEISNER AIMEE S Director Aug 08 '24 Proposed Sale 120.00 25,000 3,000,000 Aug 08 12:15 PM Gilliam Joseph E PRESIDENT & COO Jul 05 '24 Option Exercise 69.30 2,250 155,925 104,095 Jul 09 05:10 PM Gilliam Joseph E PRESIDENT & COO Jul 05 '24 Sale 121.39 2,250 273,128 101,845 Jul 09 05:10 PM Gilliam Joseph E PRESIDENT & COO Jun 03 '24 Option Exercise 55.18 2,500 137,950 104,345 Jun 05 07:35 PM Gilliam Joseph E PRESIDENT & COO Jun 03 '24 Sale 113.50 2,500 283,751 101,845 Jun 05 07:35 PM Kliman Gilbert H Director May 30 '24 Option Exercise 32.00 5,000 160,000 35,620 Jun 03 09:00 PM Kliman Gilbert H Director May 30 '24 Sale 112.00 5,000 560,000 30,620 Jun 03 09:00 PM Stapley Marc Director May 15 '24 Option Exercise 32.00 6,250 200,000 38,610 May 16 07:45 PM Stapley Marc Director May 15 '24 Sale 112.80 6,250 704,993 32,360 May 16 07:45 PM Gilliam Joseph E PRESIDENT & COO May 10 '24 Option Exercise 55.18 2,395 132,156 104,240 May 14 04:43 PM Gilliam Joseph E PRESIDENT & COO May 10 '24 Sale 110.56 2,395 264,791 101,845 May 14 04:43 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER May 10 '24 Sale 110.51 353 39,011 51,647 May 14 04:41 PM Gilliam Joseph E PRESIDENT & COO May 06 '24 Option Exercise 55.18 105 5,794 101,950 May 08 05:21 PM Gilliam Joseph E PRESIDENT & COO May 06 '24 Sale 110.36 105 11,588 101,845 May 08 05:21 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER May 06 '24 Sale 110.26 90 9,923 52,000 May 08 05:08 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER May 02 '24 Sale 105.69 442 46,713 52,090 May 06 05:27 PM Gilliam Joseph E PRESIDENT & COO May 02 '24 Option Exercise 69.30 2,059 142,689 103,904 May 06 05:23 PM Gilliam Joseph E PRESIDENT & COO May 02 '24 Sale 105.52 2,059 217,263 101,845 May 06 05:23 PM Hoffmeister David F Director Apr 10 '24 Option Exercise 7.28 10,000 72,750 15,767 Apr 12 07:49 PM Gilliam Joseph E PRESIDENT & COO Apr 08 '24 Option Exercise 41.69 59,801 2,493,104 161,646 Apr 10 08:20 PM Gilliam Joseph E PRESIDENT & COO Apr 08 '24 Sale 100.47 59,801 6,008,359 101,845 Apr 10 08:20 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 08 '24 Sale 100.54 1,372 137,944 52,532 Apr 09 07:46 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 05 '24 Sale 96.63 262 25,316 53,904 Apr 09 07:46 PM Gilliam Joseph E PRESIDENT & COO Apr 05 '24 Option Exercise 55.18 2,457 135,577 104,302 Apr 09 07:40 PM Gilliam Joseph E PRESIDENT & COO Apr 05 '24 Sale 96.81 2,457 237,862 101,845 Apr 09 07:40 PM Gilliam Joseph E PRESIDENT & COO Apr 03 '24 Option Exercise 55.18 200 11,036 102,045 Apr 05 06:15 PM Gilliam Joseph E PRESIDENT & COO Apr 04 '24 Option Exercise 55.18 200 11,036 102,045 Apr 05 06:15 PM Gilliam Joseph E PRESIDENT & COO Apr 03 '24 Sale 96.61 200 19,322 101,845 Apr 05 06:15 PM Gilliam Joseph E PRESIDENT & COO Apr 04 '24 Sale 96.57 200 19,314 101,845 Apr 05 06:15 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 04 '24 Sale 95.33 434 41,371 54,166 Apr 05 06:13 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 03 '24 Sale 94.62 316 29,900 54,600 Apr 05 06:13 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 02 '24 Sale 90.37 474 42,835 54,916 Apr 03 08:32 PM Kliman Gilbert H Director Mar 07 '24 Option Exercise 32.00 5,000 160,000 35,620 Mar 08 05:12 PM Kliman Gilbert H Director Mar 06 '24 Sale 85.34 8,347 712,307 0 Mar 08 05:12 PM Kliman Gilbert H Director Mar 07 '24 Sale 88.25 5,000 441,250 30,620 Mar 08 05:12 PM Stapley Marc Director Feb 29 '24 Option Exercise 32.00 6,250 200,000 38,610 Mar 04 08:09 PM Stapley Marc Director Feb 29 '24 Sale 90.09 6,250 563,087 32,360 Mar 04 08:09 PM Kliman Gilbert H Director Feb 27 '24 Sale 92.00 8,000 736,000 8,347 Feb 29 05:52 PM Gilliam Joseph E PRESIDENT & COO Feb 23 '24 Option Exercise 39.82 118,831 4,731,666 238,633 Feb 27 09:29 PM Gilliam Joseph E PRESIDENT & COO Feb 23 '24 Sale 92.14 140,245 12,922,002 98,388 Feb 27 09:29 PM Foley Mark J Director Feb 23 '24 Option Exercise 7.28 10,000 72,750 37,780 Feb 26 07:01 PM Foley Mark J Director Feb 23 '24 Sale 92.87 4,560 423,487 33,220 Feb 26 07:01 PM Gilliam Joseph E PRESIDENT & COO Feb 12 '24 Option Exercise 55.18 1,512 83,432 121,314 Feb 14 04:56 PM Gilliam Joseph E PRESIDENT & COO Feb 12 '24 Sale 96.80 1,512 146,362 119,802 Feb 14 04:56 PM Gilliam Joseph E PRESIDENT & COO Feb 08 '24 Option Exercise 39.10 5,000 195,500 124,802 Feb 12 06:41 PM Gilliam Joseph E PRESIDENT & COO Feb 09 '24 Option Exercise 55.18 631 34,819 120,433 Feb 12 06:41 PM Gilliam Joseph E PRESIDENT & COO Feb 08 '24 Sale 96.07 5,000 480,350 119,802 Feb 12 06:41 PM Gilliam Joseph E PRESIDENT & COO Feb 09 '24 Sale 96.70 631 61,018 119,802 Feb 12 06:41 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Feb 08 '24 Sale 95.78 550 52,682 54,035 Feb 09 06:33 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Feb 07 '24 Sale 95.00 33 3,135 54,585 Feb 09 06:33 PM Gilliam Joseph E PRESIDENT & COO Jan 29 '24 Option Exercise 39.10 9,476 370,512 129,278 Jan 31 05:35 PM Gilliam Joseph E PRESIDENT & COO Jan 29 '24 Sale 94.12 9,476 891,881 119,802 Jan 31 05:35 PM Gilliam Joseph E PRESIDENT & COO Jan 22 '24 Option Exercise 39.10 524 20,488 120,326 Jan 24 06:04 PM Gilliam Joseph E PRESIDENT & COO Jan 22 '24 Sale 94.01 524 49,261 119,802 Jan 24 06:04 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
